Crohn's Disease

Patients who have experienced gastrointestinal symptoms before the onset of depression were at increased risk for an eventual diagnosis of inflammatory bowel disease, according to research published in Gut.

In this Commentary, Gilaad G. Kaplan, MD, of the department of medicine, University of Calgary, Alberta, Canada, discusses the four epidemiological stages of inflammatory bowel disease (IBD) and reviews the forecast of disease prevalence and how disease penetration through a population evolves over time.

Ustekinumab safely maintained a long-term clinical response and remission in patients with Crohn’s disease and ulcerative colitis, according to a presentation at the American College of Gastroenterology Virtual Annual Scientific Meeting.

This award goes to a patient advocate or advocacy group that moved the needle on a disease regarding discussion in the public sphere, better communication between patients and providers and/or advocacy for legislative or regulatory action.

In an exclusive video, Rahul S. Dalal, MD, from Brigham & Women's Hospital in Boston, spoke about predictors of Stelara failure after dose intensification in patients with Crohn’s disease at the American College of Gastroenterology Annual Meeting.

In this exclusive video from the American College of Gastroenterology Virtual Annual Scientific Meeting, Laurie Keefer, PhD, from the Icahn School of Medicine at Mount Sinai discusses her presentation on the GRITT method, a resilience-based care model for patients with inflammatory bowel disease.

Congratulations to all our winners!

Patients with Crohn’s disease in their second year of treatment with Rinvoq showed sustained improvements in disease control, deep remission and quality of life, according to research presented at the American College of Gastroenterology Annual Scientific Meeting.

“I'm doing fine.” “I'm managing.” “I'm doing okay.”

Humira was efficacious and safe for treating children with moderate to severe ulcerative colitis, according to a presentation at UEG Week.